Target intelligence / Profile preview

DNA-directed RNA polymerase III subunit F (POLR3F)

Target
POLR3F
Molecular classification
Enzyme (RNA polymerase family), Transcription factor complex component (Pol III subunit), Other (Multisubunit nuclear complex protein)
01

Overview

DNA-directed RNA polymerase III subunit F (POLR3F, also called RPC6) is a core component of eukaryotic RNA polymerase III, which is a 17-subunit nuclear enzyme complex specialized in the transcription of short non-coding RNAs including tRNAs, 5S rRNA, and U6 snRNA[1][3][6]. The POLR3F subunit, homologous to yeast RPC6, primarily contributes to the formation and stability of the Pol III preinitiation complex and participates in promoter-specific transcription initiation by interacting with other subunits and transcription factors[3]. Pol III and its subunits play essential roles in RNA biology, and misregulation or mutation can lead to diseases such as hypomyelinating leukodystrophy, cancer, and increased susceptibility to viral infections[1][3][5]. POLR3F is an integral target for understanding transcriptional regulation in eukaryotes and a focus of research into novel therapeutics for related genetic and proliferative disorders[5][6].

Other names
RPC6POLR3FRNA polymerase III subunit FDNA-directed RNA polymerase III subunit RPC6
02

Mechanism of action

Enzyme inhibition (drugs may inhibit transcription initiation or elongation by interfering with Pol III complex assembly or function[5]) Disrupt disruption of protein–protein interactions within the Pol III subunit complexes

03

Biological functions

Transcription (synthesis of tRNAs, 5S rRNA, U6 snRNA, and other small non-coding RNAs)Gene expression regulationRNA processing (by providing transcription products for downstream processing and translation)Cell proliferation (indirect through RNA synthesis)Immune response (influenced by Pol III activity[5])
04

Disease associations

Cancer (misregulation can drive transformation; Pol III activity is upregulated in some cancers[5])Neurodegenerative disease (mutations in Pol III subunits linked to hypomyelinating leukodystrophy[1][3])Infection (roles in response to viral infection[5])Developmental disorders (via subunit mutations[3])
05

Safety considerations

Therapeutic targeting risk: As Pol III synthesizes essential RNAs required for basic cellular processes, inhibition carries notable risks for toxicity, especially in rapidly dividing or sensitive tissues[5].Off-target effects: Lack of selectivity among RNA polymerase classes may lead to broad gene expression inhibition.
06

Interacting drugs

No currently approved drugs known to directly target POLR3F or the Pol III complex in clinical use, but inhibitors are a research focus for cancer therapeutics[5]. Examples include investigational compounds targeting Pol III enzymatic activity.

1 more in the full profile.

07

Biomarkers

POLR3F expression levels (may serve as a biomarker for cancer or developmental disorders in research contexts[5])Mutation patterns in specific subunits (diagnostic for leukodystrophy[1][3])

Beyond the preview

Go deeper on DNA-directed RNA polymerase III subunit F (POLR3F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase III subunit F (POLR3F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call